XORTX THERAPEUTICS INC (XRTX)
Institutional ownership reported to the SEC as of Q2 2026, across 19 quarters.
6
Reporting holders
$92.8K
Reported value
0.0%
Held as options
+3
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | $52.5K | 23,116 | 0.00% | new | NEW |
| StoneX Group Inc. | $37.9K | 16,369 | 0.00% | new | NEW |
| ROYAL BANK OF CANADA | $2.0K | 732 | 0.00% | new | NEW |
| NATIONAL BANK OF CANADA /FI/ | $329 | 162 | 0.00% | new | NEW |
| Clearstead Advisors, LLC | $120 | 55 | 0.00% | 2q | -80.1% |
| TD Waterhouse Canada Inc. | $19 | 9 | 0.00% | new | NEW |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 6 | $92.8K | 40,443 | 5 | 0 | 1 | 0.0% |
| Q1 2026 | 3 | $6.2K | 15,324 | 3 | 0 | 0 | 0.0% |
| Q4 2025 | 6 | $123.6K | 230,697 | 4 | 1 | 0 | 0.0% |
| Q3 2025 | 5 | $81.5K | 100,658 | 2 | 1 | 1 | 0.0% |
| Q2 2025 | 6 | $61.2K | 65,295 | 4 | 1 | 0 | 0.0% |
| Q1 2025 | 2 | $416 | 451 | 0 | 0 | 1 | 0.0% |
| Q4 2024 | 6 | $324.4K | 286,964 | 1 | 1 | 2 | 0.0% |
| Q3 2024 | 7 | $42.3K | 24,914 | 3 | 0 | 1 | 0.0% |
| Q2 2024 | 5 | $30.4K | 15,497 | 2 | 0 | 0 | 0.0% |
| Q1 2024 | 4 | $67.2K | 16,932 | 2 | 0 | 0 | 0.0% |
| Q4 2023 | 4 | $164.9K | 2,764,045 | 4 | 0 | 0 | 0.0% |
| Q3 2023 | 4 | $9.8K | 15,491 | 1 | 1 | 0 | 0.0% |
| Q2 2023 | 4 | $26.6K | 40,994 | 1 | 0 | 0 | 0.0% |
| Q1 2023 | 5 | $27.2K | 58,572 | 2 | 1 | 0 | 0.0% |
| Q4 2022 | 6 | $1.2M | 1,516,813 | 4 | 0 | 0 | 0.0% |
| Q3 2022 | 3 | $30.0K | 25,142 | 2 | 0 | 1 | 0.0% |
| Q2 2022 | 3 | $45.0K | 33,616 | 0 | 2 | 1 | 0.0% |
| Q1 2022 | 5 | $136.0K | 69,127 | 2 | 2 | 0 | 0.0% |
| Q4 2021 | 3 | $49.0K | 24,164 | 3 | 0 | 0 | 0.0% |